key: cord-1011665-nn11xeyc
authors: Zang, Weicheng; Zheng, Xiaofeng
title: Structure and Functions of cellular redox sensor HSCARG/NMRAL1, a linkage among redox status, innate immunity, DNA damage response, and cancer
date: 2020-09-17
journal: Free Radic Biol Med
DOI: 10.1016/j.freeradbiomed.2020.09.016
sha: e0eae1fc7a141ff2a86efd31679edb370884be9e
doc_id: 1011665
cord_uid: nn11xeyc

NmrA-like proteins are NAD(P)(H) interacting molecules whose structures are similar to that of short-chain dehydrogenases. In this review, we focus on an NADP(H) sensor, HSCARG (also named NMRAL1), which is a NmrA-like protein that is widely present in mammals, and provide a comprehensive overview of the current knowledge of its structure and physiological functions. HSCARG selectively binds to the reduced form of type II coenzyme NADPH via its Rossmann fold domain. In response to reduction of intracellular NADPH concentration, HSCARG transforms from homodimer to monomer and exhibits enhanced interactions with its binding partners. In the cytoplasm, HSCARG negatively regulates innate immunity through impairing the activities of NF-κB and RLR pathways. Besides, HSCARG regulates redox homeostasis via suppression of ROS and NO generation. Intensive and persistent oxidative stress leads to translocation of HSCARG from the cytoplasm to the nucleus, where it regulates the DNA damage response. Taken together, HSCARG functions as a linkage between cellular redox status and other signaling pathways and fine-tunes cellular response to redox changes.

Nitrogen metabolite repressor (NmrA) is a transcription repressor which is involved in regulation of nitrogen metabolism in Aspergillus nidulans. A. nidulans uses a wide array of small-molecule compounds as its source of nitrogen, including ammonium, nitrate, glutamate, and arginine. When A. nidulans cells are able to simultaneously intake sufficient amount of these compounds from environment, ammonium and glutamate are preferentially utilized. During the above phenomenon known as nitrogen metabolite repression, NmrA is highly expressed to inhibit the transcription of enzymes participating in nitrate or arginine catabolism [1, 2] . The structure of NmrA, resembling that of the short-chain dehydrogenase/reductase (SDR) superfamily, consists of an N-terminal Rossmann fold and a C-terminal domain [3] .

and NADP(H). However, NmrA is incapable of catalyzing dehydrogenation reactions because the crucial tyrosine enzymatic site within the Rossmann fold is mutated to methionine. Interestingly, NmrA binds to NAD + and NADP + with much higher affinities in comparison with their reduced form, suggesting a potential role of NmrA in redox sensing. Specifically, in the complex of NmrA with coenzymes, residue Tyr-276 is very close to the nicotinamide in space. Therefore, an additional hydrogen atom present at the C4-position in the reduced nicotinamide leads to steric clashes with the hydroxyl group on the side chain of Tyr-276 [4] . So far, the regulatory effects of NAD + and NADP + on NmrA in nitrogen metabolite repression have remained incompletely elucidated.

Since the structure of NmrA was resolved, researchers have discovered several

The HSCARG gene is located in chromosome 16 

Homo sapiens and Mus musculus. The crystal structure of human HSCARG protein was revealed via X-ray diffraction in 2007 [8, 9] , after which the interaction proteins of HSCARG and its regulatory functions and mechanisms were clarified (Fig. 1A, 1C,   1D ). The amino acid sequence of HSCARG protein has a high similarity among species (Fig. 1B) . Human HSCARG can be essentially divided into an N-terminal Rossmann fold consisting of residues 1-219 and a C-terminal domain consisting of residues 220-299 (Fig. 1C) . The central parallel β-sheet of the Rossmann fold domain is composed of β-strands 1-6 interconnected by α-helixes 1-7 ( Fig. 2A) .

Although the overall topology of HSCARG is nearly identical to that of NmrA, HSCARG binds to the reduced form of NADPH (but not NADH) with a much higher affinity. Correspondingly, there is no residue similar to NmrA Thr-276 in the C-terminal region of HSCARG. A total of 20 hydrogen bonds are formed between NADPH and the Rossmann fold of HSCARG, making the association extremely tight in vitro. 6 of the 20 hydrogen bonds are formed between residues Thr-13, Arg-37, and

Lys-41 and the extra 2'-phosphate on the AMP moiety, which accounts for selective binding of HSCARG to the type II coenzyme NADPH [9] . Indeed, there is normally high selectivity for one type of coenzyme in the case of SDRs, and NADP-specific SDRs commonly contain a pair of conserved basic residues, which are similar to Arg-37 and Lys-41 in HSCARG, that provide the discrimination by interacting with the 2'-phosphate [10].

HSCARG exists in three different forms in vivo: (i) NADPH-bound monomers;

(ii) NADPH-unbound monomers; (iii) asymmetrical dimers with one subunit binding to NADPH (molecule I) and the other unoccupied (molecule II). Redox status fine-tuned concentration of NADPH regulates the equilibrium among these three forms (Fig. 1E) . The major conformational alterations of HSCARG upon NADPH J o u r n a l P r e -p r o o f 5 binding are reorientation of residue Tyr-81 to form hydrogen bonds with the NMP moiety and rotation of residue Gly-123, which changes the secondary structure of residues 127-143 to a complete α-helix [9]. As SDR family proteins commonly undergo oligomerization, the NADPH-bound HSCARG can associate with a second molecule of HSCARG which is free of coenzyme [11] . The formation of asymmetrical HSCARG dimer which exhibits unique surface characteristics further stabilizes the interaction between molecule I and NADPH and prevents binding of molecule II to coenzyme. Mutation of either residue R37 or Y81A to alanine abrogates the binding of HSCARG to NADPH. As a result, mutants R37A and Y81A only exist as monomers in vivo, while their overall structures are similar to the NADPH-bound molecule I of the wild-type HSCARG dimer. In contrast, mutant K41S retains the capability of homodimerization because serine, unlike alanine, is able to form similar hydrogen bond with NADPH as lysine [12] . In comparison to the wild-type protein, mutants R37A and Y81A, but not mutant K41S, exhibit enhanced interactions with their binding partners, indicating that formation of asymmetrical dimers inactivates the regulatory functions of HSCARG [13, 14] .

Under normal redox status, HSCARG is predominantly located in the cytoplasm surrounding the nucleus and associates with intermediate filaments [9] . Enrichment of HSCARG in the cytoplasm is mediated by a leucine-rich nuclear export signal (NES) at residues 272-278 that induces nuclear export of HSCARG in a CRM1-dependent manner. Loss of C-terminal residues 272-299 or point mutations within NES sequester HSCARG to the nucleus [15] . Besides, redistribution of HSCARG is observed in response to decreased intracellular ratio of NADPH/NADP + , which could be realized by targeting NADPH-producing enzymes. Three categories of enzymes are able to reduce NADPH from its oxidized form, which are glucose-6-phosphate dehydrogenase (G6PD) in the pentose phosphate pathway, isocitrate dehydrogenase (IDH) in the tricarboxylic acid cycle, and malic enzyme in the pyruvate cycling J o u r n a l P r e -p r o o f 6 pathway [16] . Activities of G6PD and IDH are inhibited by endogenous steroid dehydroepiandrosterone (DHEA) and signaling molecule nitric oxide (NO), respectively [17, 18] . Therefore, treatment with DHEA or SNAP, a commonly used NO donor, and overexpression of argininosuccinate synthetase (ASS), a rate-limiting enzyme in NO regeneration, lead to dissociation of HSCARG from intermediate filaments and translocation of HSCARG from the cytoplasm to the nucleus [14, 19] .

HSCARG is a negative regulator of innate immunity. In response to infection with RNA viruses, RIG-I-like receptors recognize cytosolic viral RNA and trigger type I interferon production through a Cardif-TRAF3-TBK1/IKKε-IRF3 axis [20, 21] .

K63-polyubiquitination of TRAF3 stimulates the above signal transduction process by enhancing the interaction between TRAF3 and IKKε, while HSCARG cooperates with deubiquitinase OTUB1 to remove the ubiquitin chain from TRAF3 ( Fig. 2A) .

Accordingly, overexpression of HSCARG impairs the recruitment of IKKε, decreases the phosphorylation and nuclear translocation of IRF3, and thereby downregulates the level of IFN-β after viral infection [22] .

Besides the RLR pathway, HSCARG suppresses cytokine-induced nuclear factor-κB (NF-κB) activation. NF-κB is a heterodimer composed of subunits p50 and p65 [23] . In resting cells, interaction between NF-κB and IκB proteins sequesters p65 and p50 in the cytoplasm, thereby inhibiting the transcription activity of both factors.

In the canonical NF-κB signaling pathway, receptors on the cell membrane recognize cytokines such as tumor necrosis factors (TNF) or interleukin 1 (IL-1) and transduce signals to the IκB kinase (IKK) complex through ubiquitination reaction cascade.

Activated IKK complex then phosphorylates IκB, which subsequently leads to ubiquitination and proteasome-mediated degradation of IκB, and thus permits nuclear translocation of p50 and p65 to execute their transcription regulatory functions [24, 25] . While mounting reports have confirmed the suppressive effects of HSCARG on TNF and IL-1-induced NF-κB activation, different underlying mechanisms were complexes, and thereby facilitates the dephosphorylation of IKKβ by PP2A and deubiquitination of NEMO by USP7 [26] [27] [28] (Fig. 2A) . On the other hand, HSCARG interacts with COMMD1, a copper metabolism regulator which is also involved in negative regulation of NF-κB pathway through stabilizing IκBα and promoting degradation of p65 [29, 30] . Specifically, under normal physiological conditions, cytosolically located HSCARG accelerates the K48-polyubiquitination and subsequent degradation of COMMD1. In response to redox changes resulted from DHEA or SNAP treatment, nuclear translocation of HSCARG relieves its inhibitory effect on COMMD1 [31] . Experiments with the same reporting system showed that repression of HSCARG on the transcription activity of NF-κB was significantly attenuated in IKKβ knockdown cells, but not in COMMD1-depleted cells, indicating that HSCARG primarily functions through the former mechanism. HSCARG binds to both IKK subunits and COMMD1 via residues 1-153, which constitutes the central core of the Rossmann fold. Notwithstanding, HSCARG truncation 154-299 is still able to suppress NF-κB activation, although with decreased efficiency in comparison to the full-length protein [27, 31] . This suggests that the C-terminal domain of HSCARG is involved in modulation of NF-κB activation via an alternative mechanism which is independent of the IKK complex or COMMD1.

Knockdown of G6PD enhances the susceptibility of human lung carcinoma cells to coronavirus infection through a HSCARG-mediated mechanism. It was observed that in G6PD-depleted A549 cells, transcription of NF-κB downstream antiviral genes, including TNF-α and MX1, is impaired upon infection with HCoV-229E, which consequently promotes viral replication. The effect could be rescued through J o u r n a l P r e -p r o o f 8 knockdown of HSCARG [32] . It is worth mentioning that deficiencies in G6PD lead to decreased intracellular ratio of NADPH/NADP + and depolymerization of inactive HSCARG dimer into monomers. Therefore, the foregoing observation is a vivid example how redox changes active the function of HSCARG in NF-κB regulation.

As a consequence of inhibition of NF-κB activation, HSCARG impairs the recruitment of p65 to the promotor of p47phox and reduces the transcription of p47phox, a subunit of NADPH oxidase. NADPH oxidase catalyzes the transfer of electron from NADPH to oxygen, which generates NADP + and reactive oxygen species (ROS) [33] . Moderate concentration of ROS is essential for microbial killing, while excessive production of intracellular ROS through NADPH oxidase leads to over-consumption of NADPH and accumulation of oxidative damages. Upregulation of HSCARG decreases the endogenous protein level of p47phox, downregulates the catalytic activity of NADPH oxidase, and thus prevents overproduction of ROS [34] ( Fig. 2B) .

Another important molecule that influences cellular redox status is NO.

Production of NO in the cytoplasm is catalyzed by nitic oxide synthase (NOS) at the consumption of arginine and NADPH. Arginine is the sole precursor of NO in cells;

hence synthesis of NO is rate-limited by availability of arginine. Besides being transported from extracellular fluid, intracellular arginine can be recycled from citrulline, the co-product of NOS, through successive actions of argininosuccinate synthetase and argininosuccinate lyase [19] . As shown in Fig. 2B , HSCARG interacts directly with ASS via residues 153-189 and attenuates the activity of ASS and production of NO [14] .

As mentioned above, in response to decreased NADPH, disaggregation of HSCARG dimer into monomers activates its regulatory functions. Accordingly, enhancement of interaction between HSCARG and ASS was observed in DHEA-treated cells, proving that the ability of HSCARG to impair arginine recycling J o u r n a l P r e -p r o o f 9 and NO synthesis is activated after dissociation with NADPH [14] . The conclusion was reinforced by the fact that HSCARG NADPH-unbound mutants R37A and Y81A, which exists only as monomer, exhibit increased interaction with ASS and more efficient inhibitory effects on p47phox protein level in comparison to the wild-type protein [12, 13] . Considering both NADPH oxidase-catalyzed ROS production and NOS-catalyzed NO production are couple with oxidation of NADPH into NADP + , one can speculate that HSCARG might regulate NADPH homeostasis via feedback inhibition of NADPH-consuming pathways and promote cell resistance against oxidative stress. Further studies are necessary to clarify the real functional effects of HSCARG on intracellular NADPH level.

In the nucleus, HSCARG retains its interaction with deubiquitinase USP7.

HSCARG cooperates with and depends on USP7 to inhibit the ubiquitination of core components of polycomb repressive complex 1 (PRC1). PRC1 is an E3 ligase complex that catalyzes mono-ubiquitination of histone H2A at Lys-119, while the self-ubiquitination of PRC1 is crucial for its catalytic activity [35, 36] . Ubiquitination of H2A plays a vital role in the DNA damage response to double-strand break (DSB) through providing docking sites for DSB downstream repair proteins such as RAP80 and 53BP1 [37] . In response to ionizing radiation (IR), HSCARG suppresses PRC1-mediated H2A ubiquitination in a USP7-dependent manner (Fig. 3) . Deletion of HSCARG increases the persistence of H2A ubiquitination in IR-treated cells, which further leads to retention of RAP80 at DNA lesion sites [38] .

HSCARG also regulates the translesion synthesis (TLS) pathway that targets ultraviolet (UV) radiation-induced lesions during DNA replication. UV radiation leads to autocleavage and subsequent degradation of USP1, and thereby abolishes the deubiquitination effects of USP1 on its substrate PCNA [39] . Mono-ubiquitination of PCNA at Lys-164 then recruits polymerase eta (POLH) to bypass the UV-damaged sites [40] . HSCARG directly interacts with PCNA via its PCNA-interacting protein J o u r n a l P r e -p r o o f (PIP)-box at residues 133-140, which is highly conserved among species (Fig. 1B) .

Moreover, HSCARG stimulates the deubiquitination of PCNA by enhancing the interaction between USP1 and PCNA (Fig. 3) . Overexpression of HSCARG partly rescues UV-induced decrease of chromatin-associated USP1 level. As a result, upregulation of HSCARG or nuclear enrichment of HSCARG caused by high dosage of SNAP treatment block the accumulation of POLH at replication stalling sites in response to UV radiation, which leads to collapse of replication forks and generation of DSBs [13] .

The role of HSCARG in NF-κB signaling, ROS generation and DNA damage response implies its biological relevance to cancer. On the one hand, overproduction of ROS contributes to genomic instability via introduction of oxidative DNA damages and constitutive activation of NF-κB promotes cell proliferation while prevents apoptosis [41, 42] . Therefore, the inhibitory effects of HSCARG on ROS and NF-κB in the cytoplasm ought to suppress cancer development. On the other hand, enrichment of HSCARG in the nucleus leads to deficiencies in TLS and DSB repair, which elevates genome mutation rate. Thus it can be seen that subcellular localization of HSCARG counterbalances its oncogenic and tumor suppressive functions. Indeed, bioinformatics analysis reveals that HSCARG is highly expressed in various types of cancer. Consistently, deletion of HSCARG in female polyomavirus middle T antigen (PyMT) transgenic mice delays the genesis of breast carcinoma. Interestingly, in newly developed tumors from PyMT mice, the upregulated HSCARG protein accumulate in the nucleus, which is most likely due to oxidative stress in the microenvironment [13] . This observation reinforces the conclusion that negative regulation of DNA damage response in the nucleus is, at least in part, responsible for the oncogenic effects of HSCARG (Fig. 3) .

As summarized here, HSCARG participates in regulation of cellular redox homeostasis, innate immunity, and the DNA damage response; the functions of HSCARG are deeply associated with post-translational modifications of key components in these pathways. HSCARG interacts directly with deubiquitinases OTUB1, USP1, and USP7 and stimulates their deubiquitination effects on substrates.

These observations indicate that inhibition of substrate ubiquitination via recruitment of deubiqutinases is a regular functional mode of HSCARG. Further studies should focus on identification of other HSCARG binding partners, especially among deubiquitinase family members, to reveal the potential functions of HSCARG in other pathways.

As a NmrA-like protein, HSCARG is unable to the catalyze metabolic reactions independently due to mutation of the crucial tyrosine enzymatic site within the Rossmann fold into histidine (His-129). It is natural to assume that HSCARG is derived from duplication and mutation of SDR family members. Usually, genes with loss-of-function mutations are subjected to negative selection during evolution.

However, HSCARG is widely conserved in higher species in spite of its incapability of dehydrogenation. This suggests that HSCARG must play a positive role in other aspects. Under normal physiological conditions, the functions of HSCARG are silenced due to NADPH-promoted homodimerization. Oxidative stress-caused reduction in NADPH concentration plays a dual role on HSCARG. On the one hand, upon dissociation from NADPH, HSCARG transforms from functionally inactive homodimer to active monomer. Indeed, it was observed that treatment of cells with moderate amount of SNAP (50 μM) and DHEA (100 μM) activated the interaction between HSCARG and ASS and elevated the inhibitory effect of HSCARG on ROS production [13, 14] . On the other hand, over-enrichment of HSCARG in the nucleus under violent and persistent oxidative stress attenuates its functions in the cytoplasm.

For example, an excess of SNAP (500 μM) and diethylmaleate (2 mM) impaired the interaction between HSCARG and ASS and attenuated the suppression of HSCARG on NF-κB activity [14, 15] . The current observations on behaviors of HSCARG in response to redox change are predominantly based on cell-based assays. Therefore, further researches should focus on the phenotype differences between HSCARG wild-type and knockout mice fed or injected with drugs that cause oxidative stress.

Taken together, HSCARG functions as a linkage between cellular redox status and other signaling pathways and fine-tunes cellular response to redox changes. In canonical NF-κB signaling, HSCARG cooperates with USP7 and PP2A to inhibit the K63-polyubiqutination of NEMO and phosphorylation of IKKβ, thereby decreasing the activity of IKK complex, repressing the degradation of IκBα, and restraining NF-κB in the cytoplasm. In RLR pathway, HSCARG stimulates the deubiquitination of TRAF3 by OTUB1, which further attenuates the phosphorylation of IKKε and IRF3, and finally decreases the production of type I interferons; (B) HSCARG is involved in intracellular NADPH homeostasis. Decrease in NADPH concentration leads to disaggregation of HSCARG dimer into monomers, and thus activates its functions. HSCARG reduces overproduction of NO and ROS via suppressing the activity of ASS and blocking the transcription of p47phox, respectively. 

Characterization of the Aspergillus nidulans nmrA gene involved in nitrogen metabolite repression

The GATA factors AREA and AREB together with the co-repressor NMRA, negatively regulate arginine catabolism in Aspergillus nidulans in response to nitrogen and carbon source

The structure of the negative transcriptional regulator NmrA reveals a structural superfamily which includes the short-chain dehydrogenase/reductases

The negative transcriptional regulator NmrA discriminates between oxidized and reduced dinucleotides

Crystal structure of a new type of NADPH-dependent quinone oxidoreductase (QOR2) from Escherichia coli

A new protein carrying an NmrA-like domain is required for cell differentiation and development in Dictyostelium discoideum

Cellular redox sensor HSCARG negatively regulates the translesion synthesis pathway and exacerbates mammary tumorigenesis

An NADPH sensor protein (HSCARG) down-regulates nitric oxide synthesis by association with argininosuccinate synthetase and is essential for epithelial cell viability

A CRM1-dependent nuclear export signal controls nucleocytoplasmic translocation of HSCARG, which regulates NF-kappaB activity

Quantifying interactions within the NADP(H) enzyme network in Drosophila melanogaster

Inactivation of NADP(+)-dependent isocitrate dehydrogenase by nitric oxide

Effect of dehydroepiandrosterone on human erythrocytes redox metabolism: inhibition of glucose-6-phosphate dehydrogenase activity in vivo and in vitro

Regulation of nitric oxide production by arginine metabolic enzymes

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif

HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

Shared principles in NF-kappaB signaling

Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor

HSCARG inhibits activation of NF-kappaB by interacting with IkappaB kinase-beta

HSCARG downregulates NF-kappaB signaling by interacting with USP7 and inhibiting NEMO ubiquitination

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase

HSCARG regulates NF-kappaB activation by promoting the ubiquitination of RelA or COMMD1

Glucose-6-Phosphate Dehydrogenase Enhances Antiviral Response through Downregulation of NADPH Sensor HSCARG and Upregulation of NF-kappaB Signaling

Redox signalling involving NADPH oxidase-derived reactive oxygen species

HSCARG inhibits NADPH oxidase activity through regulation of the expression of p47phox

Role of histone H2A ubiquitination in Polycomb silencing

The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity

Polycomb group proteins in the DNA damage response: a link between radiation resistance and "stemness

HSCARG, a novel regulator of H2A ubiquitination by downregulating PRC1 ubiquitin E3 ligase activity, is essential for cell proliferation

Regulation of monoubiquitinated PCNA by DUB autocleavage

Y-family DNA polymerases and their role in tolerance of cellular DNA damage

Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-kappaB signaling

Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell

The authors declare that they have no competing interests.J o u r n a l P r e -p r o o f

HSCARG is a NmrA-like protein that selectively binds to reduced form of type II coenzyme NADPH. In response to oxidative stress, HSCARG disaggregates from homodimer to monomer and translocates from the cytoplasm to the nucleus. HSCARG suppresses innate immunity pathways and impairs production of nitric oxide in the cytoplasm. HSCARG downregulates DNA damage response and promotes cancer development in the nucleus.